Our latest New Psychoactive Substances panels utilize our cutting-edge Biochip Array Technology, providing multiplex testing capabilities that are both rapid and accurate.
Our cutting-edge patented Biochip Array Technology allows for the detection of a vast range of drug classes from a single sample. The biochip is a solid state device with discrete test sites onto which antibodies specific to different drug compounds are immobilised and stabilised. Competitive chemiluminescent immunoassays are then employed, offering a highly sensitive screen. Designed to work across a wide variety of matrices, this revolutionary multi-analyte testing platform allows toxicologists to achieve a complete immunoassay profile in the initial screening phase.